Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Serum Metabolite Range Expanded Through Technology

By LabMedica International staff writers
Posted on 16 Mar 2011
Analytical technology has identified numerous blood metabolites in human serum that doctors can potentially look at to diagnose and treat health problems.

The metabolites that can be detected in human serum along with their respective concentrations and disease association have been revealed using a variety of techniques. More...


Scientists at the University of Alberta, (Edmonton, AB, Canada), have analyzed blood components to ascertain the most definitive human-serum metabolome to date. The data also includes chemicals found in the blood plasma. More than 20 scientists at six different institutions used state of the art technology to validate past research. The team also conducted its own laboratory experiments to break new ground on the content of human blood chemistry.

They used the following methods with mass spectroscopy (MS): gas chromatography (GC-MS); thin layer chromatography (TLC/GC-MS), liquid chromatography (LC-MS), ultrahigh performance liquid chromatography (UPLC-MS/MS), and direct flow injection (DFI -MS/MS) to identify, quantify and validate more than 4,000 plasma and serum metabolites. High-resolution nuclear magnetic resonance (NMR) spectroscopy was also used. The human serum metabolome database, created by the scientists is open access, allowing anyone to log on and find the expanded list of blood chemicals. Doctors can now tap into the collected wisdom of hundreds of blood-research projects done in the past by scientists all over the world

David Wishart, PhD, a lead author of the study, said, "Right now a medical doctor analyzing the blood of an ailing patient looks at something like 10 to 20 chemicals. We have identified 4,229 blood chemicals that doctors can potentially look at to diagnose and treat health problems. This is the most complete chemical characterization of blood ever done. We now know the normal values of all the detectable chemicals in blood. Doctors can use these measurements as a reference point for monitoring a patient's current and even future health." The study was published on February 16, 2011, in the journal Public Library of Science, PLoS One.

Related Links:

University of Alberta
The human serum metabolome database


Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Human Estradiol Assay
Human Estradiol CLIA Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.